Dialysis Facility Overpayment Refunds: How to Self-Disclose and Return Medicare Overpayments Correctly
A guide for dialysis facilities on returning Medicare overpayments: the 60-day rule as revised in 2025, the 180-day good-faith investigation suspension, the six-year lookback, MAC voluntary refunds, extrapolation, OIG's Self-Disclosure Protocol, the CMS SRDP, and documenting the process.
KNOWLEDGE CENTER
11/15/202611 min read
When a dialysis facility discovers that it was paid for services that did not meet Medicare requirements, it has a legal obligation to report and return the overpayment. Overpayments can come from many sources: treatments billed but not documented, drug units billed that exceed administration, unsupported comorbidity adjustments, training add-ons without documented sessions, consolidated billing errors, or Medicare secondary payer mistakes. OIG's audits of dialysis facilities have recommended that providers exercise diligence to identify and return overpayments.
The rules changed in 2025. CMS revised the overpayment regulation at 42 CFR 401.305, effective January 1, 2025, to align the definition of an identified overpayment with the False Claims Act knowledge standard and to suspend the 60-day deadline for up to 180 days while a provider conducts a timely, good-faith investigation. Facilities also have several options for returning overpayments, depending on the nature of the problem.
This article explains the overpayment obligation, the 2025 changes, how to investigate and quantify overpayments, the routes for returning them, and how to document the process. It is educational and does not replace legal or professional advice. Facilities should involve counsel when overpayments may involve potential fraud.
The Overpayment Obligation
The Statute
Section 1128J(d) of the Social Security Act requires a person who has received an overpayment to report and return it to the Secretary, the state, an intermediary, a carrier, or a contractor, as appropriate, and to notify the recipient in writing of the reason for the overpayment. The overpayment must be reported and returned by the later of 60 days after the date it was identified or the date any corresponding cost report is due, if applicable. An overpayment retained after the deadline is an obligation under the False Claims Act.
The Regulation
CMS implemented the statute for Medicare Parts A and B at 42 CFR 401.305. Overpayments must be reported and returned if identified within six years of the date the overpayment was received, which is the lookback period.
The 2025 Changes
When an Overpayment Is Identified
Under the revised regulation effective January 1, 2025, a person has identified an overpayment when the person knowingly receives or retains an overpayment, using the False Claims Act's definition of knowingly, which includes actual knowledge, deliberate ignorance, or reckless disregard. This replaced the prior standard, which tied identification to the exercise of reasonable diligence and quantification.
The 180-Day Suspension
The revised regulation at 42 CFR 401.305(b)(3) suspends the 60-day deadline when a person has identified an overpayment but has not completed a timely, good-faith investigation to determine whether related overpayments exist. The suspension lasts until the earlier of the date the investigation concludes and the aggregate amount is calculated, or 180 days after the initial overpayment was identified. If the person does not conduct a timely, good-faith investigation, the 60-day deadline applies without suspension.
What This Means in Practice
Facilities must act quickly when a potential overpayment is found. The clock starts when an overpayment is identified, not when it is fully quantified. If related overpayments may exist, the facility should promptly begin and document a good-faith investigation to take advantage of the suspension. Facilities should record the date of initial identification and the date the investigation begins.
Investigating Overpayments
Step 1: Preserve and Escalate
When staff identify a potential overpayment, they should report it to compliance. Compliance should preserve records, document the date of identification, and determine whether related overpayments may exist.
Step 2: Define the Scope
Determine the nature of the error, the services and claims affected, the time period, and the facilities and patients involved. For example, if a billing system error caused drug units to be overbilled, identify all claims processed by that logic during the relevant period.
Step 3: Review Claims
Review claims to confirm errors and calculate amounts. For large populations, a statistically valid random sample may be used to estimate the overpayment. The Medicare Program Integrity Manual and CMS guidance describe statistical sampling principles, and OIG's Self-Disclosure Protocol describes sampling requirements for disclosures, such as a minimum sample size.
Step 4: Calculate the Overpayment
Calculate the amount Medicare paid that should not have been paid. Under the ESRD PPS, an error in an adjustment, such as a comorbidity code, may affect only part of a payment, while an undocumented treatment may affect the entire per-treatment payment. Consider beneficiary coinsurance that must also be refunded.
Step 5: Determine Root Cause and Correct
Identify why the error occurred and implement corrective actions, such as system fixes, training, and policy changes, so the problem does not continue.
Step 6: Decide on the Return Route
Choose the appropriate route for returning the overpayment, described below.
Step 7: Document Everything
Maintain documentation of identification, investigation, calculation, return, corrective actions, and communications.
Routes for Returning Overpayments
MAC Voluntary Refunds and Claim Adjustments
For most billing errors without potential fraud, facilities can return overpayments by adjusting or canceling claims through the MAC, or by submitting a voluntary refund using the MAC's overpayment refund form. The form generally requires information about the claims, the reason for the refund, and the method used to calculate the amount, including whether statistical sampling was used. When sampling is used, MACs may require details of the methodology. Facilities should follow their MAC's instructions.
Cost Report Corrections
When the overpayment relates to cost report items, such as bad debts or cost allocations, the correction may be made through an amended cost report or a reopening request, subject to applicable rules.
OIG Health Care Fraud Self-Disclosure Protocol
When an overpayment involves potential fraud, such as conduct that may violate the Anti-Kickback Statute or the False Claims Act, a refund to the MAC alone may not resolve the provider's potential liability. OIG's Health Care Fraud Self-Disclosure Protocol, updated November 8, 2021, provides a process for disclosing potential fraud to OIG. Key features include:
• A requirement that the disclosing party acknowledge that the conduct is a potential violation.
• A complete investigation and damages calculation, which may use statistical sampling with a minimum sample size.
• A general practice of settling for a minimum multiplier of 1.5 times single damages, lower than would typically apply in a government-initiated investigation.
• Minimum settlement amounts, which the 2021 update increased to $20,000 for most matters and $100,000 for matters involving the Anti-Kickback Statute.
• Tolling of the 60-day deadline when the disclosure is accepted, consistent with the overpayment regulation.
OIG has reported that, between the protocol's launch in 1998 and 2020, it resolved more than 2,200 self-disclosures, and that self-disclosing parties rarely are required to enter corporate integrity agreements.
CMS Voluntary Self-Referral Disclosure Protocol
When a potential violation involves only the physician self-referral law, providers may use CMS's Voluntary Self-Referral Disclosure Protocol. Dialysis facilities have financial relationships with nephrologists, such as medical director agreements and joint ventures, and lab and other designated health services issues can implicate the law, so facilities should evaluate this protocol with counsel.
Department of Justice
Providers may also disclose potential False Claims Act violations to the Department of Justice, which has its own voluntary self-disclosure policies. The choice of route depends on the facts and should be made with counsel.
Dialysis-Specific Overpayment Scenarios
Undocumented Treatments
If treatments were billed without documentation that they were furnished, the full per-treatment payment for those treatments is generally an overpayment.
Drug Units
If a billing interface overstated drug units, the overpayment may include affected outlier payments and TDAPA amounts.
Comorbidity and Onset Adjustments
If adjustments were claimed without support, the overpayment is the difference between the adjusted and unadjusted payment.
Training Add-On
If training sessions were billed without documentation, the add-on amounts and related payments may be overpayments.
Consolidated Billing
If ESRD-related labs or drugs were billed separately by another entity, or by the facility on another claim type, duplicate payments may need to be returned.
Medicare Secondary Payer
If Medicare paid as primary during a coordination period, the facility should refund Medicare and bill the primary payer.
Low-Volume Adjustment
If a facility received the low-volume adjustment without meeting eligibility, the adjustment amounts may be overpayments.
Medicaid and Other Payers
Dialysis facilities also bill Medicaid, Medicare Advantage, and commercial payers. Section 1128J(d) applies to Medicaid overpayments, which must be returned to the state under state procedures. Medicare Advantage overpayments are generally handled under contracts with plans. Facilities should apply consistent processes across payers.
Patient Refunds
When an overpayment includes beneficiary coinsurance, the facility must refund the beneficiary or the secondary payer that paid it. Facilities should document beneficiary refunds.
Documentation Best Practices
Maintain an overpayment file for each matter that includes:
• The date and description of initial identification.
• The decision on whether related overpayments may exist and the date the investigation began.
• The investigation plan, scope, and methodology.
• Claim lists, sampling plans, and calculations.
• Root cause analysis and corrective actions.
• Copies of refund submissions, disclosures, and correspondence.
• Confirmation of repayment and beneficiary refunds.
A well-documented file demonstrates good faith and compliance with the 60-day rule if questions arise later.
Building an Overpayment Response Program
• Adopt a written overpayment policy that reflects the 2025 regulation.
• Train staff to report potential overpayments promptly.
• Designate a compliance owner for each matter.
• Use a tracking log with key dates.
• Establish criteria for involving counsel and considering self-disclosure.
• Report overpayment matters to the compliance committee and board.
• Use findings to improve audits and training.
A Hypothetical Example
A dialysis organization's internal audit identifies that a billing system update caused hemoglobin values from the wrong month to be reported on ESA claims at several facilities. Compliance records the date of identification, begins an investigation the next week, and determines through system analysis that the error affected four months of claims at five facilities. The organization determines that the reporting error affected modifier application and calculates the payment impact. It fixes the system, corrects claims through the MACs within the suspension period, refunds affected coinsurance, and documents each step. Because the matter involved an inadvertent billing error rather than potential fraud, counsel advises that a MAC refund is appropriate.
When a Billing Error Becomes a Potential Fraud Issue
Not every overpayment involves fraud. Most result from billing errors, system problems, or documentation gaps. However, some situations may raise potential fraud concerns, such as knowing submission of false claims, arrangements that may violate the Anti-Kickback Statute, or patterns that suggest intentional upcoding. Factors that may indicate a more serious issue include involvement of leadership, deliberate concealment, financial arrangements with referral sources, or repeated errors after the organization was aware of the problem. When these factors are present, the facility should involve counsel promptly, consider the OIG or DOJ disclosure routes, and preserve privilege where appropriate.
Financial Relationships in Dialysis
Dialysis facilities often have financial relationships with nephrologists, including medical director agreements, joint ventures, and leases. These relationships must comply with the Anti-Kickback Statute and, where designated health services are involved, the physician self-referral law. Facilities also must be cautious about patient inducements, such as assistance with insurance premiums or transportation, which can raise beneficiary inducement concerns. When a compliance review finds a problem with a financial relationship, the potential liability may exceed a simple overpayment, and disclosure options should be evaluated with counsel.
Extrapolation and Statistical Sampling
When an overpayment affects many claims, facilities may use statistical sampling to estimate the total. A valid sampling approach includes defining the universe of claims, selecting a random sample of adequate size, reviewing each sampled claim, and extrapolating the results to the universe. OIG's Self-Disclosure Protocol requires a minimum sample size for disclosures that use sampling. MACs may accept extrapolated refunds, but they may ask for the methodology. Using a qualified statistician improves accuracy and defensibility.
Common Myths About Overpayments
Myth: The 60-Day Clock Starts When the Amount Is Calculated
Under the 2025 rule, the clock starts when the overpayment is identified, with a suspension of up to 180 days for a timely, good-faith investigation.
Myth: Small Overpayments Can Be Ignored
The obligation applies regardless of amount.
Myth: A MAC Refund Resolves All Liability
A refund returns the overpayment, but it may not resolve potential liability for fraud. Disclosure through OIG or DOJ may be needed in those cases.
Myth: Waiting Is Safer
Retaining an identified overpayment past the deadline creates False Claims Act risk.
Questions Leadership Should Ask
• Does our overpayment policy reflect the 2025 regulation?
• Do we document the date each overpayment is identified?
• Do we start investigations promptly?
• How do we decide whether to involve counsel or self-disclose?
• Are beneficiary refunds tracked?
• Are root causes corrected and verified?
Key Takeaways
• Overpayments must be reported and returned within 60 days of identification, with a suspension of up to 180 days for a timely, good-faith investigation.
• The 2025 rule ties identification to the False Claims Act knowledge standard.
• Facilities must look back six years.
• Routes include MAC refunds, cost report corrections, OIG's Self-Disclosure Protocol, CMS's SRDP, and DOJ disclosure.
• Documentation of each step demonstrates good faith.
Coordinating With Audits in Progress
If a facility identifies an overpayment while a contractor or OIG audit is in progress, it should consider how to coordinate. Returning overpayments that are within the scope of an ongoing audit may require communication with the auditor. Counsel can advise on whether to disclose findings to the auditor, how to handle overlapping claims, and how to avoid duplicate repayments. Facilities should not delay returning identified overpayments simply because an audit is pending, but should coordinate carefully.
Overpayments Identified Through Audits
When an external audit identifies overpayments, the facility may also have obligations to look for similar overpayments outside the audit sample. OIG's dialysis audit recommendations, for example, included exercising reasonable diligence to identify, report, and return similar overpayments under the 60-day rule. Facilities should evaluate whether the audit findings indicate broader issues and investigate accordingly.
Board Oversight
Governing bodies should receive regular reports on overpayment matters, including the number of matters, amounts returned, root causes, and corrective actions. Board oversight is an element of an effective compliance program and demonstrates that leadership takes repayment obligations seriously. Board minutes should reflect these reviews.
Training Staff on Reporting
Front-line staff are often the first to notice billing errors. Training should explain what an overpayment is, why prompt reporting matters, and how to report concerns, including anonymously through a compliance hotline. Facilities should reinforce that reporting is expected and protected from retaliation.
Lessons From Recent Enforcement
Government enforcement actions in health care often involve failures to return known overpayments, sometimes discovered through whistleblower lawsuits under the False Claims Act. Many of these cases began with internal reports that were not acted upon. Facilities that respond promptly to internal reports, investigate in good faith, and document their actions reduce the risk that a billing error becomes a False Claims Act case.
Working With Outside Advisors
Outside advisors can help with complex investigations, statistical sampling, and disclosure decisions. Counsel can advise on legal exposure and privilege, statisticians can design defensible samples, and consultants can review claims and documentation. Defining roles clearly at the start of an investigation keeps the process efficient.
Measuring the Program
Track the number of potential overpayments reported, the time from identification to investigation, the time to repayment, the amounts returned, and recurrence of similar issues. These measures help compliance leaders assess whether the program is working and whether repayment deadlines are being met consistently. Reporting these measures to leadership and the board each quarter keeps repayment obligations visible across the organization.
Avoiding Common Mistakes
Common mistakes include failing to record the identification date, starting investigations late, using informal estimates without a defensible methodology, forgetting beneficiary refunds, and failing to fix the root cause before the next billing cycle.
Avoiding these mistakes keeps facilities within deadlines.
Timely action also preserves the suspension period.
Document each decision as it is made.
Frequently Asked Questions
When is an overpayment identified under the 2025 rule?
When a person knowingly receives or retains an overpayment, using the False Claims Act knowledge standard.
How long do facilities have to return an overpayment?
Generally 60 days after identification, suspended for up to 180 days while a timely, good-faith investigation of related overpayments is conducted.
How far back must facilities look?
Six years from the date the overpayment was received.
When should a facility use OIG's Self-Disclosure Protocol?
When the matter involves potential fraud, such as potential Anti-Kickback Statute or False Claims Act violations, rather than simple billing errors.
What is the minimum settlement under OIG's protocol?
Generally $20,000, or $100,000 for Anti-Kickback Statute matters, with a general minimum multiplier of 1.5 times single damages.
Conclusion
Returning overpayments correctly protects dialysis facilities from False Claims Act liability and demonstrates an effective compliance program. Facilities that act quickly, document the date of identification, conduct timely good-faith investigations, calculate overpayments carefully, choose the right return route, refund beneficiaries, and fix root causes will meet their obligations under the revised 60-day rule.
How HealthBridge Can Help
HealthBridge is a healthcare management consulting firm that helps dialysis facilities investigate potential overpayments, design sampling and calculation methods, prepare refund submissions, coordinate with counsel on self-disclosures, and implement corrective actions. If your facility has identified a potential overpayment, please get in touch with us. We will be happy to help you with this topic.
References
• U.S. Social Security Administration. Social Security Act, Section 1128J, Medicare and Medicaid Program Integrity Provisions. https://www.ssa.gov/OP_Home/ssact/title11/1128J.htm
• Electronic Code of Federal Regulations. 42 CFR 401.305, Requirements for Reporting and Returning of Overpayments. https://www.ecfr.gov/current/title-42/chapter-IV/subchapter-A/part-401/subpart-D/section-401.305
• Federal Register. Medicare and Medicaid Programs; CY 2025 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies (December 9, 2024). https://www.federalregister.gov/documents/2024/12/09/2024-25382/medicare-and-medicaid-programs-cy-2025-payment-policies-under-the-physician-fee-schedule-and-other
• U.S. Department of Health and Human Services, Office of Inspector General. Health Care Fraud Self-Disclosure Protocol (amended November 8, 2021). https://oig.hhs.gov/documents/featured-topics/11834/Health_Care_Fraud_Self-Disclosure-Protocol.pdf
• U.S. Department of Health and Human Services, Office of Inspector General. Self-Disclosure Information. https://oig.hhs.gov/compliance/self-disclosure-info/
• Centers for Medicare & Medicaid Services. Self-Referral Disclosure Protocol. https://www.cms.gov/medicare/regulations-guidance/physician-self-referral/self-referral-disclosure-protocol
• Centers for Medicare & Medicaid Services. Medicare Financial Management Manual, Chapter 3, Overpayments. https://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/downloads/fin106c03.pdf
• Centers for Medicare & Medicaid Services. Medicare Program Integrity Manual, Chapter 8, Administrative Actions and Statistical Sampling for Overpayment Estimation. https://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/downloads/pim83c08.pdf
• U.S. Department of Health and Human Services, Office of Inspector General. Medicare Dialysis Services Provider Compliance Audit: Dialysis Clinic, Inc. (A-05-20-00010). https://oig.hhs.gov/oas/reports/region5/52000010.asp
• Office of the Law Revision Counsel. 31 U.S.C. 3729, False Claims. https://uscode.house.gov/view.xhtml?req=granuleid:USC-prelim-title31-section3729&num=0&edition=prelim

Some or all of the services described herein may not be permissible for HealthBridge US clients and their affiliates or related entities.
The information provided is general in nature and is not intended to address the specific circumstances of any individual or entity. While we strive to offer accurate and timely information, we cannot guarantee that such information remains accurate after it is received or that it will continue to be accurate over time. Anyone seeking to act on such information should first seek professional advice tailored to their specific situation. HealthBridge US does not offer legal services.
HealthBridge US is not affiliated with any department of public health agencies in any state, nor with the Centers for Medicare & Medicaid Services (CMS). We offer healthcare consulting services exclusively and are an independent consulting firm not affiliated with any regulatory organizations, including but not limited to the Accrediting Organizations, the Centers for Medicare & Medicaid Services (CMS), and state departments. HealthBridge is an anti-fraud company in full compliance with all applicable federal and state regulations for CMS, as well as other relevant business and healthcare laws. The badges, icons, and achievement graphics displayed on this website represent proprietary performance metrics, volume milestones, and internal corporate recognition issued exclusively by our corporate affiliate network at SummitRidge. These visual markers are utilized solely as historical indicators of enterprise growth, operational longevity, and volume-based milestones cleared within our shared corporate ecosystem.
© 2026 HealthBridge US, a California corporation. All rights reserved.
For more information about the structure of HealthBridge, visit www.myhbconsulting.com/governance
